Review
Sep 2026
Advances in imaging for systemic sclerosis.
A. Lescoat, Laura Ross, C. Bergmann et al.
· Rheumatology · 0 citations
We have 3 of 1,946 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Open access
Aug 2026
Long-term outcomes of anti-CD19 CAR T cell therapy in refractory myasthenia gravis: A case series.
Anti-CD19 CAR T cell therapy represents an emerging therapeutic approach for generalized, treatment-refractory myasthenia gravis (MG), a predominantly B-cell-mediated autoimmune disease for which durable treatment-free remission remains an unmet clinical goal. Despite recent advances, current targeted therapies general...
T. Hegelmaier, J. Motte, Denise Walther et al.
· Cell Reports Medicine · 0 citations
Aug 2026
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.
CD19 CAR T cells showed acceptable short-term tolerability in patients with treatment-refractory RA, justifying further evaluation, and the primary endpoint was met, allowing advancement to phase 2.
F. Albach, Marie C. Rehm, M. Hütter-Krönke et al.
· Nature Medicine · 0 citations